Is Elevance Health Inc. (ELV) a Buy, Sell, or Hold?
NYSE : ELV
Elevance Health Inc.
$377.68 USD
-$1.63 (-0.43%)
- Volume
- 734.83K
- Average Volume
- 1.74M
- Market Capitalization
- $81.91B
- P/E Ratio
- 16.79
- Dividend Yield
- 1.82%
- Price Target
- $452.50
- Year High
- $436.24
- Year Low
- $273.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.30
- Current Ratio
- $1.52
Company Overview
NYSE
Gail Koziara Boudreaux
Medical - Healthcare Plans
Healthcare
ELV
97100
US
USD
Liquidity Metrics
0.69
1.52
1.52
0.23
0.30
Sales & Valuation
$199.12B
0.41
1.83
13.02
28.86
Profitability
$25.12
$5.66B
2.47%
2.91%
11.24%
3.93%
P/E Metrics
16.79
-3.73
-3.73
Analyst Price Target & Rating
$452.50
$498.00
$391.00
3/5
38 Analysts
-16.53%
Financial Health Scores
2.59
8/9
$22.93B
$126.44B
$81.42B
$6.99B
Key Metrics (TTM)
$102.72B
0.51
12.83
1.52
11.24%
7.22%
6.03%
7.68%
$324.90
42 days
Company Executives
| Name | Title |
|---|---|
| Charles Morgan Kendrick Jr. | EVP and President of Commercial & Specialty Health Benefits |
| Mark Bradley Kaye | Executive Vice President & Chief Financial Officer |
| Nathan Allen Rich | Vice President of Investor Relations |
| Peter David Haytaian | Special Advisor |
| Ronald William Penczek | Senior Vice President, Controller & Chief Accounting Officer |
| Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer |
| Erin Wessling | Executive VP & Chief Legal Officer |
| Felicia Farr Norwood | Executive VP & Chief Health Benefits Officer |
| Gail Koziara Boudreaux | President, Chief Executive Officer & Director |
| Julie Goon | Senior Vice President of Public Affairs |
Poll Results
No votes yet today — be the first to share your view!
About Elevance Health Inc. (NYSE:ELV) Stock
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc. ...
Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?
2026-07-25 11:30:51
Seth Klarman's Baupost Group rarely shows its cards, so when the latest 13F filing (holdings as of March 31, 2026, filed May 14, 2026) disclosed his five largest long common-stock positions, the disclosure read like a treasure map.
Bessemer Group Inc. Has $1.26 Million Holdings in Elevance Health, Inc. $ELV
2026-07-24 05:08:59
Bessemer Group Inc. lessened its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 97.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,297 shares of the company's stock after selling 138,897 shares during the quarter. Bessemer Group Inc.'s
Elevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by Brokerages
2026-07-23 02:29:21
Shares of Elevance Health, Inc. (NYSE: ELV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-three ratings firms that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average
Acumen Wealth Advisors LLC Has $2.03 Million Stock Holdings in Elevance Health, Inc. $ELV
2026-07-22 03:55:11
Acumen Wealth Advisors LLC decreased its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 51.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,935 shares of the company's stock after selling 7,357 shares during the quarter. Acumen Wealth Advisors
Artisan Value Fund Q2 2026 Portfolio Update
2026-07-21 11:25:00
US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.
2026-07-20 08:53:01
The purchase of 1,000 shares at $366.05 per share represents a total capital commitment of $366,050. This transaction increased the director's total direct equity position by 10% relative to his pre-trade holdings.
Elevance Health Q2 Earnings Call Highlights
2026-07-18 04:46:50
Elevance Health (NYSE: ELV) raised its 2026 adjusted earnings outlook after second-quarter results came in ahead of management's expectations, citing favorable benefit expense performance, disciplined cost management and improving execution across several major business lines. President and CEO Gail Boudreaux said the company now expects 2026 adjusted diluted earnings per share of at least $27. Chief
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?
2026-07-17 15:35:43
The CEO executed an open-market purchase of 2,725 shares, representing a capital commitment of ~$1.0 million. The transaction increased the insider's total equity holdings by 2% of the previously held position.
Frequently Asked Questions
-
What is the current Elevance Health Inc. (ELV) stock price?
-
Elevance Health Inc.(NYSE:ELV) stock price is $377.68 in the last trading session. During the trading session, ELV stock reached the peak price of $436.24 while $273.71 was the lowest point it dropped to. The percentage change in ELV stock occurred in the recent session was --0.43% while the dollar amount for the price change in ELV stock was -$1.63.
-
ELV's industry and sector of operation?
-
The NYSE listed ELV is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector.
-
Who are the executives of ELV?
-
Charles Morgan Kendrick Jr. | EVP and President of Commercial & Specialty Health Benefits
Mark Bradley Kaye | Executive Vice President & Chief Financial Officer
Nathan Allen Rich | Vice President of Investor Relations
Peter David Haytaian | Special Advisor
Ronald William Penczek | Senior Vice President, Controller & Chief Accounting Officer -
How many employees does ELV have?
-
Number of ELV employees currently stands at 97100. ELV operates from 220 Virginia Avenue, Indianapolis, IN 46204, US.
-
Link for ELV official website?
-
Official Website of ELV is: https://www.elevancehealth.com
-
How do I contact ELV?
-
ELV could be contacted at phone #800 331 1476 and can also be accessed through its website. ELV operates from 220 Virginia Avenue, Indianapolis, IN 46204, US.
-
How many shares of ELV are traded daily?
-
The average number of ELV shares traded daily for last 3 months was 1.74M.
-
What is the market cap of ELV currently?
-
The market value of ELV currently stands at $81.91B with its latest stock price at $377.68